Rho Management Trust I - Net Worth and Insider Trading
Rho Management Trust I Net Worth
The estimated net worth of Rho Management Trust I is at least $4 Million dollars as of 2024-09-20. Rho Management Trust I is the 10% Owner of Senomyx Inc and owns about 2,688,973 shares of Senomyx Inc (SNMX) stock worth over $4 Million. Details can be seen in Rho Management Trust I's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rho Management Trust I has not made any transactions after 2004-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rho Management Trust I
Rho Management Trust I Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rho Management Trust I owns 4 companies in total, including Anacor Pharmaceuticals Inc (ANAC) , IntraLinks Holdings Inc (IL) , and Vanda Pharmaceuticals Inc (VNDA) among others .
Click here to see the complete history of Rho Management Trust I’s form 4 insider trades.
Insider Ownership Summary of Rho Management Trust I
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2011-12-20 | 10 percent owner |
| IL | IntraLinks Holdings Inc | 2011-12-20 | 10 percent owner |
| VNDA | Vanda Pharmaceuticals Inc | 2006-11-06 | 10 percent owner |
 | | 2005-03-03 | 10 percent owner |
Rho Management Trust I Latest Holdings Summary
Rho Management Trust I currently owns a total of 1 stock. Rho Management Trust I owns 2,688,973 shares of Senomyx Inc (SNMX) as of June 25, 2004, with a value of $4 Million.
Latest Holdings of Rho Management Trust I
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNMX | Senomyx Inc | 2004-06-25 | 2,688,973 | 1.49 | 4,006,570 |
Holding Weightings of Rho Management Trust I
Rho Management Trust I Form 4 Trading Tracker
According to the SEC Form 4 filings, Rho Management Trust I has made a total of 0 transactions in Senomyx Inc (SNMX) over the past 5 years. The most-recent trade in Senomyx Inc is the acquisition of 250,000 shares on June 25, 2004, which cost Rho Management Trust I around $2 Million.
Insider Trading History of Rho Management Trust I
- 1
Rho Management Trust I Trading Performance
GuruFocus tracks the stock performance after each of Rho Management Trust I's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rho Management Trust I is 49.01%. GuruFocus also compares Rho Management Trust I's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rho Management Trust I within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rho Management Trust I's insider trading performs compared to the benchmark.
Performance of Rho Management Trust I
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.79 | | | | | |
| Relative Return to S&P 500(%) | 11.04 | | | | | |
Rho Management Trust I Ownership Network
Rho Management Trust I Owned Company Details
What does Anacor Pharmaceuticals Inc do?
Who are the key executives at Anacor Pharmaceuticals Inc?
Rho Management Trust I is the 10 percent owner of Anacor Pharmaceuticals Inc. Other key executives at Anacor Pharmaceuticals Inc include Executive VP and CFO Graeme Bell , EVP and General Counsel Ryan T Sullivan , and director & President and CEO Paul L Berns .
Anacor Pharmaceuticals Inc (ANAC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Anacor Pharmaceuticals Inc (ANAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anacor Pharmaceuticals Inc (ANAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Anacor Pharmaceuticals Inc (ANAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Anacor Pharmaceuticals Inc Insider Transactions
Rho Management Trust I Mailing Address
Above is the net worth, insider trading, and ownership report for Rho Management Trust I. You might contact Rho Management Trust I via mailing address: C/o Rho Capital Partners, Inc., 152 W. 57th Street, 23rd Floor, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
